Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
* Reuters is not responsible for the content in this press release.
SEATTLE, Oct. 29 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN)
today announced that management will present at the following upcoming
investor conferences.
Merriman Investor Summit 2009
New York City
Tuesday, November 10, 2009
11:00 a.m. ET
Credit Suisse 2009 Healthcare Conference
Phoenix, Arizona
Friday, November 13, 2009
11:30 a.m. ET
Lazard Capital Markets 6th Annual Healthcare Conference
New York City
Tuesday, November 17, 2009
10:55 a.m. ET
The presentations will be audio webcast live and available for replay from
Dendreon's website, www.dendreon.com.
Dendreon Corporation is a biotechnology company whose mission is to target
cancer and transform lives through the discovery, development and
commercialization of novel therapeutics. The Company applies its expertise in
antigen identification, engineering and cell processing to produce active
cellular immunotherapy product candidates designed to stimulate an immune
response. Dendreon is also developing an orally-available small molecule that
targets TRPM8 that could be applicable to multiple types of cancer as well as
benign prostatic hyperplasia. The Company has its headquarters in Seattle,
Washington and is traded on the Nasdaq Global Market under the symbol DNDN.
For more information about the Company and its programs, visit
www.dendreon.com.
SOURCE Dendreon Corporation
Jennifer Williams, Investor Relations of Dendreon Corporation,
+1-206-829-1500
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters